Skip to Content

C 070 (PhenazoForte Plus butabarbital 15 mg / hyoscyamine hydrobromide 0.3 mg / phenazopyridine hydrochloride 150 mg)

Generic Name: butabarbital/hyoscyamine/phenazopyridine

Pill with imprint C 070 is Red, Capsule-shape and has been identified as PhenazoForte Plus butabarbital 15 mg / hyoscyamine hydrobromide 0.3 mg / phenazopyridine hydrochloride 150 mg. It is supplied by Creekwood Pharmaceutical, Inc..

PhenazoForte Plus is used in the treatment of dysuria and belongs to the drug class urinary antispasmodics. There is positive evidence of human fetal risk during pregnancy. PhenazoForte Plus butabarbital 15 mg / hyoscyamine hydrobromide 0.3 mg / phenazopyridine hydrochloride 150 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for C 070

Phenazoforte plus butabarbital 15 mg / hyoscyamine hydrobromide 0.3 mg / phenazopyridine hydrochloride 150 mg C 070

PhenazoForte Plus

Generic Name:
butabarbital/hyoscyamine/phenazopyridine
Imprint:
C 070
Strength:
butabarbital 15 mg / hyoscyamine hydrobromide 0.3 mg / phenazopyridine hydrochloride 150 mg
Color:
Red
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Urinary antispasmodics
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Creekwood Pharmaceutical, Inc.
National Drug Code (NDC):
15310-0070

Get help with Imprint Code FAQs.

More about PhenazoForte Plus (butabarbital / hyoscyamine / phenazopyridine)

Professional resources

Related treatment guides

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide